Ad is loading...
ATHA
Price
$0.67
Change
-$0.04 (-5.63%)
Updated
Nov 15 closing price
123 days until earnings call
MNKD
Price
$6.80
Change
-$0.22 (-3.13%)
Updated
Nov 15 closing price
107 days until earnings call
Ad is loading...

ATHA vs MNKD

Header iconATHA vs MNKD Comparison
Open Charts ATHA vs MNKDBanner chart's image
Athira Pharma
Price$0.67
Change-$0.04 (-5.63%)
Volume$670.02K
CapitalizationN/A
MannKind
Price$6.80
Change-$0.22 (-3.13%)
Volume$5.22M
CapitalizationN/A
ATHA vs MNKD Comparison Chart
Loading...
ATHA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MNKD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ATHA vs. MNKD commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATHA is a StrongSell and MNKD is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (ATHA: $0.67 vs. MNKD: $6.80)
Brand notoriety: ATHA and MNKD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATHA: 11% vs. MNKD: 226%
Market capitalization -- ATHA: $25.91M vs. MNKD: $1.88B
ATHA [@Biotechnology] is valued at $25.91M. MNKD’s [@Biotechnology] market capitalization is $1.88B. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATHA’s FA Score shows that 1 FA rating(s) are green whileMNKD’s FA Score has 1 green FA rating(s).

  • ATHA’s FA Score: 1 green, 4 red.
  • MNKD’s FA Score: 1 green, 4 red.
According to our system of comparison, MNKD is a better buy in the long-term than ATHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATHA’s TA Score shows that 5 TA indicator(s) are bullish while MNKD’s TA Score has 2 bullish TA indicator(s).

  • ATHA’s TA Score: 5 bullish, 4 bearish.
  • MNKD’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, ATHA is a better buy in the short-term than MNKD.

Price Growth

ATHA (@Biotechnology) experienced а +1.55% price change this week, while MNKD (@Biotechnology) price change was -7.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

ATHA is expected to report earnings on Mar 20, 2025.

MNKD is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MNKD($1.88B) has a higher market cap than ATHA($25.9M). MNKD YTD gains are higher at: 86.813 vs. ATHA (-72.424). MNKD has higher annual earnings (EBITDA): 53.3M vs. ATHA (-120.43M). MNKD has more cash in the bank: 248M vs. ATHA (91.8M). ATHA has less debt than MNKD: ATHA (1.41M) vs MNKD (231M). MNKD has higher revenues than ATHA: MNKD (248M) vs ATHA (0).
ATHAMNKDATHA / MNKD
Capitalization25.9M1.88B1%
EBITDA-120.43M53.3M-226%
Gain YTD-72.42486.813-83%
P/E RatioN/A85.00-
Revenue0248M-
Total Cash91.8M248M37%
Total Debt1.41M231M1%
FUNDAMENTALS RATINGS
MNKD: Fundamental Ratings
MNKD
OUTLOOK RATING
1..100
82
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
19
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
84
SEASONALITY SCORE
1..100
28

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATHAMNKD
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
68%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
77%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 13 days ago
83%
Bullish Trend 12 days ago
87%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 5 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
74%
Aroon
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
74%
View a ticker or compare two or three
Ad is loading...
ATHA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MNKD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBHAX14.39-0.05
-0.35%
Neuberger Berman Equity Income A
CBFEX38.10-0.22
-0.57%
American Funds Global Balanced 529E
VELAX17.79-0.14
-0.78%
VELA Large Cap Plus A
MGOYX14.69-0.22
-1.48%
Victory Munder Mid-Cap Core Growth Y
CHCCX4.17-0.09
-2.11%
AB Discovery Growth C

ATHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHA has been loosely correlated with ALNY. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHA jumps, then ALNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHA
1D Price
Change %
ATHA100%
-6.12%
ALNY - ATHA
35%
Loosely correlated
-8.67%
OGEN - ATHA
34%
Loosely correlated
-2.49%
PCVX - ATHA
33%
Poorly correlated
-6.31%
MNKD - ATHA
32%
Poorly correlated
-3.13%
SNGX - ATHA
31%
Poorly correlated
-3.80%
More

MNKD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNKD has been loosely correlated with QSI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if MNKD jumps, then QSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNKD
1D Price
Change %
MNKD100%
-3.13%
QSI - MNKD
44%
Loosely correlated
-5.77%
NTLA - MNKD
44%
Loosely correlated
-7.61%
VCYT - MNKD
44%
Loosely correlated
-2.97%
BEAM - MNKD
43%
Loosely correlated
-8.59%
PGEN - MNKD
42%
Loosely correlated
-7.11%
More